LAB

Standard Biotools Inc

LAB.US standardbio.com + Research + Basket
CIK 0001162194
Employees 385
Phone 650 266 6000
Fiscal year end December
IPO Jul 29, 2003
Address 50 Milk Street, Boston, MA, United States, 02109
0.62
+0.00 (+0.15%)
USD · NASDAQ
52-week range
0.59
1.72
Trading at 3% of the 52-week range
Market Cap
236.83M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
1.38
Div. Yield
N/A
% Institutions
75.27%
% Insiders
1.83%

1 Year

-51.4%

3 Year

-68.0%

10 Year

-86.7%
Description

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.

Actions

Add an action for LAB.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Michael Egholm Ph.D. President, CEO & Director 1963
Mr. Hanjoon Kim Chief Financial Officer 1971
Mr. Sean Mackay Senior VP & Chief Business Officer 1982
Mr. Jonathan Mickelsen VP & Chief Accounting Officer NA
John Graziano Vice President of Investor Relations NA
Ms. Elizabeth R. Jensen Chief Human Resources Officer 1974
Mr. Anders Davas Senior Vice President of Global Operations NA
Mr. Mike Musgnug Senior VP & Chief Commercial Officer NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Dec 04, 2025 Casdin Partners Master Fund, L N/A Purchase 150.00K $1.45 $217.50K SEC
Dec 03, 2025 Casdin Partners Master Fund, L N/A Purchase 75.00K $1.44 $108.00K SEC
Dec 02, 2025 Casdin Partners Master Fund, L N/A Purchase 125.00K $1.42 $177.50K SEC
Nov 25, 2025 Casdin Partners Master Fund, L N/A Purchase 7.55M $1.30 $9.82M SEC
Nov 24, 2025 Casdin Partners Master Fund, L N/A Purchase 150.00K $1.43 $214.50K SEC
Nov 20, 2025 Casdin Partners Master Fund, L N/A Purchase 450.00K $1.30 $585.00K SEC
Nov 19, 2025 Casdin Partners Master Fund, L N/A Purchase 350.00K $1.28 $448.00K SEC
Nov 18, 2025 Casdin Partners Master Fund, L N/A Purchase 275.00K $1.23 $338.25K SEC
Nov 17, 2025 Casdin Partners Master Fund, L N/A Purchase 225.00K $1.22 $274.50K SEC
Nov 14, 2025 Casdin Partners Master Fund, L N/A Purchase 250.00K $1.24 $310.00K SEC
Nov 13, 2025 Casdin Partners Master Fund, L N/A Purchase 450.00K $1.20 $540.00K SEC
Nov 12, 2025 Casdin Partners Master Fund, L N/A Purchase 375.00K $1.19 $446.25K SEC
Nov 11, 2025 Casdin Partners Master Fund, L N/A Purchase 300.00K $1.20 $360.00K SEC
Nov 10, 2025 Casdin Partners Master Fund, L N/A Purchase 275.00K $1.17 $321.75K SEC
Nov 07, 2025 Casdin Partners Master Fund, L N/A Purchase 225.00K $1.12 $252.00K SEC
Sep 09, 2025 Casdin Partners Master Fund, L N/A Purchase 100.00K $1.29 $129.00K SEC
Sep 03, 2025 Casdin Partners Master Fund, L N/A Purchase 250.00K $1.27 $317.50K SEC
Aug 26, 2025 Casdin Partners Master Fund, L N/A Purchase 125.00K $1.26 $157.50K SEC
Aug 25, 2025 Casdin Partners Master Fund, L N/A Purchase 200.00K $1.24 $248.00K SEC
Aug 22, 2025 Casdin Partners Master Fund, L N/A Purchase 200.00K $1.26 $252.00K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Casdin Capital, LLC 88.78M Jun 30, 2026 22.62% $3.66 0.00%
Viking Global Investors LP 58.65M Jun 30, 2026 14.94% $0.14 0.00%
Mak Capital One LLC 28.81M Jun 30, 2026 7.34% $3.32 10.09%
Long Focus Capital Management, LLC 23.50M Jun 30, 2026 5.99% $0.49 46.73%
Vanguard Capital Management, LLC 12.25M Jun 30, 2026 3.12% $0.00 -4.39%
BlackRock Inc 8.25M Jun 30, 2026 2.10% $0.00 -66.66%
Hollow Brook Wealth Management, LLC 5.50M Jun 30, 2026 1.40% $0.90 -2.65%
Neuberger Berman Group LLC 4.96M Jun 30, 2026 1.26% $0.00 6.46%
Qube Research & Technologies 4.82M Jun 30, 2026 1.23% $0.00 584.33%
Royce & Associates, LP 4.53M Jun 30, 2026 1.15% $0.03 50.57%
Geode Capital Management, LLC 3.90M Jun 30, 2026 0.99% $0.00 -46.54%
Tikvah Management LLC 3.55M Jun 30, 2026 0.90% $0.89 0.00%
Millennium Management LLC 3.51M Jun 30, 2026 0.89% $0.00 67.11%
Morgan Stanley - Brokerage Accounts 2.83M Jun 30, 2026 0.72% $0.00 -1.92%
D. E. Shaw & Co LP 2.82M Jun 30, 2026 0.72% $0.00 1,315.50%
Jane Street Group LLC 2.51M Jun 30, 2026 0.64% $0.00 0.00%
Peapod Lane Capital LLC 2.41M Jun 30, 2026 0.61% $1.34 18.88%
Citadel Advisors Llc 2.35M Jun 30, 2026 0.60% $0.00 91.67%
Mink Brook Asset Management LLC 2.19M Jun 30, 2026 0.56% $0.80 0.00%
Sone Capital Management 2.13M Jun 30, 2026 0.54% $0.13 20.76%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 8.68M 2.20% ▲ 0.00% Sep 30, 2026
2 iShares Biotechnology ETF 2.93M 0.74% ▼ 0.75% Sep 30, 2026
3 Schwab US Small-Cap ETF™ 1.47M 0.37% ▲ 0.07% Sep 30, 2026
4 Fidelity Extended Market Index 1.38M 0.35% ▼ 11.79% Aug 31, 2026
5 Neuberger Intrinsic Value I 1.04M 0.26% ▲ 0.00% Sep 30, 2026
6 Vanguard Health Care ETF 683.65K 0.17% ▲ 0.11% Sep 30, 2026
7 Morgan Stanley Inst Inception I 654.87K 0.17% ▲ 0.00% Jun 30, 2026
8 Fidelity Total Market Index 557.85K 0.14% ▲ 2.18% Aug 31, 2026
9 EQ/Morgan Stanley Small Cap Growth K 503.51K 0.13% ▲ 0.00% Aug 31, 2026
10 iShares Healthcare Innov ETF USD Acc 501.42K 0.13% ▲ 0.38% Sep 30, 2026

Financial Highlights

▼
Market Cap: $236.83M
EBITDA: $-53.07M
Book Value: $1.38
Earnings/Share: $-0.13
Profit Margin: 100.37%
Operating Margin: -38.94%
ROA (TTM): -6.61%
ROE (TTM): -11.18%
Revenue (TTM): $84.60M
Revenue/Share (TTM): $0.22
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -7.60%

Valuation Metrics

Enterprise Value: $-211.81M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 394.71M
Shares Float: 184.62M
% Insiders: 1.83%
% Institutions: 75.27%
Short % Float: 1.05%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$85.33M
Cost of Goods Sold
adjust
$-42.79M
Gross Profit
subtotal
$42.54M
SG&A
adjust
$-109.86M
R&D
adjust
$-25.99M
Operating Income
subtotal
$-93.31M
Other / Non-Operating Items
adjust
$18.41M
Net Income
subtotal
$-74.90M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about LAB.US!